Colorcon's breakthrough for direct compression

15 May 2019

New starch-based excipient plays an important role in enhancing the stability of moisture-sensitive APIs.

Colorcon announces an exciting new starch tableting excipient - StarTab - designed specifically for the direct compression process.

Colorcon's breakthrough for direct compression

In recent years, formulation scientists have become increasingly interested in direct compression (DC) tablet manufacturing processes. In response to this market trend, Colorcon has developed StarTab, Directly Compressible Starch. This represents a breakthrough for the DC process, where StarTab’s unique particle size and shape provides excellent flow and superior compressibility on high-speed compression machines; enabling formulation scientists to simplify tablet formulation and manufacturing. StarTab also plays an important role in enhancing the stability of moisture-sensitive active pharmaceutical ingredients.

Dr Ali Rajabi-Siahboomi, Chief Scientific Officer at Colorcon explains: “Through extensive market and scientific research using particle engineering, we designed StarTab to be used as a single ingredient for the direct compression process. As StarTab uses material that is accepted by regulatory bodies across the world; there are no barriers to adoption of the product.”

Jayesh Parmar, General Manager, Colorcon says: “The launch of this latest innovation meets the needs of the pharmaceutical industry for direct compression and is an advanced addition complementing the portfolio of solutions we provide through our starch product line.”

Read More

Related news

Improving gut health with human milk oligosaccharides

Improving gut health with human milk oligosaccharides

17 May 2019

2’-FL a very promising agent for digestive health across various age groups beyond infancy.

Read more 
Expert forecasts huge growth in Middle East manufacturing

Expert forecasts huge growth in Middle East manufacturing

16 May 2019

UAE consumers and insurance companies are willing to pay for highest quality drug products.

Read more 
Legacy plans for lyophilisation boom

Legacy plans for lyophilisation boom

14 May 2019

The increase in biologics is driving the growth in demand for lyophilization in vials.

Read more 
Lessons learned from early EU FMD adopters

Lessons learned from early EU FMD adopters

13 May 2019

Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

Read more 
Catalent achieves global ISO accreditation

Catalent achieves global ISO accreditation

12 May 2019

Company is one of the first CDMOs to receive award.

Read more 
Vibalogics increases capacity with a new 200-L line for virus manufacturing

Vibalogics increases capacity with a new 200-L line for virus manufacturing

9 May 2019

Company has also invested in an Äkta-ready chromatography system for downstream processing and liquid handling equipment to deal with increased volumes.

Read more 
New SIMCA 16 software for multivariate data analytics

New SIMCA 16 software for multivariate data analytics

8 May 2019

Makes model data easier to interpret for better process control.

Read more 
Recipharm launches its end-to-end inhalation offering

Recipharm launches its end-to-end inhalation offering

7 May 2019

Offers a seamless outsourcing service for inhalation products, including MDIs, DPIs and nasal sprays.

Read more 
Accessible online courses designed to improve tablet compression tooling

Accessible online courses designed to improve tablet compression tooling

7 May 2019

I Holland launches online training for all levels of pharmaceutical and nutraceutical professionals.

Read more 
WuXi AppTec acquisition enhances its biometrics services for clinical development

WuXi AppTec acquisition enhances its biometrics services for clinical development

6 May 2019

Acquisition will help customers to shorten time-to-market of new drugs.

Read more